Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2002
08/07/2002EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes
08/07/2002EP1228769A1 Symbiotic regenerative composition
08/07/2002EP1228767A1 Use of beta-Glucuronidase for the treatment of immune or allergic diseases
08/07/2002EP1228234A2 Production of chimeric capsid vectors
08/07/2002EP1228232A2 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
08/07/2002EP1228222A2 Human transferase molecules
08/07/2002EP1228221A2 Human sphingosine kinase gene
08/07/2002EP1228125A2 Process for making aqueous coated beadlets
08/07/2002EP1228092A1 24 human secreted proteins
08/07/2002EP1228073A2 Imidazole compounds used as phosphodiesterase vii inhibitors
08/07/2002EP1228071A1 Pharmaceutically active isoindoline derivatives
08/07/2002EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
08/07/2002EP1228068A1 Polymorphic form of a tachykinin receptor antagonist
08/07/2002EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity
08/07/2002EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
08/07/2002EP1228059A1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
08/07/2002EP1228055A1 Dihydroaminobenzo[b]- and [c]furans as retinoid-like agents
08/07/2002EP1228054A1 Compounds and their use as cysteine protease inhibitors
08/07/2002EP1228047A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist
08/07/2002EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors
08/07/2002EP1228042A2 Tetrahydroquinoline derivatives having retinoid-like biological activity
08/07/2002EP1228039A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
08/07/2002EP1228037A1 Compounds having mif antagonist activity
08/07/2002EP1227831A2 Interferon gamma for the treatment of asthma
08/07/2002EP1227813A1 Reverse-turn mimetics and methods relating thereto
08/07/2002EP1227812A2 Topical nasal treatment using desloratadine
08/07/2002EP1227805A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
08/07/2002EP0888336B1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
08/07/2002EP0874843B1 Substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases
08/07/2002EP0809517B1 Anti-transforming growth factor-beta gene therapy
08/07/2002CN1362960A Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones
08/07/2002CN1362953A Pyrazole compositions useful as inhibitors of ERK
08/07/2002CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands
08/07/2002CN1362947A N-cyanomethylamides as protease inhibitors
08/07/2002CN1362259A Application of nim extract in medicine
08/07/2002CN1362243A Nano toxic expelling medicine with five ingredients and its preparation
08/07/2002CN1362235A Nano lung-strengthening lily medicine and its preparation
08/07/2002CN1362234A Nano asthma-calming giant gecko medicine and its preparation
08/07/2002CN1362233A Nano medicine for strengthening body's resistance and treating dyspnenic cough and its preparation
08/07/2002CN1362232A Nano medicine of cinnamoni, Aconiti preparata and rehmannia and its preparation
08/07/2002CN1362231A Nano Haizhu Chuanxiding medicine and its preparation
08/07/2002CN1362227A Nano medicine for snake bile and tangerine peel and its preparation
08/07/2002CN1362224A Nano Tankejing medicine for eliminating phlegm and its preparation
08/07/2002CN1362221A Nano medicine for nourishing Yin and clearing away lung heat and its preparation
08/07/2002CN1362219A Nano Zhichuanling medicine for treating asthma and its preparation
08/07/2002CN1362212A Nano mixed heartleaf houttuynia herb medicine and its preparation
08/07/2002CN1362209A Nano bezoar medicine for treating upper respiratory tract infection and its preparation
08/07/2002CN1362205A Nano cough-relieving medicine and its preparation
08/07/2002CN1362203A Nano cold treating medicine of antelope's horn and its preparation
08/07/2002CN1362181A Nano fritillary-loquat medicine and its preparation
08/07/2002CN1362172A Nano dyspneic cough eliminating medicine and its preparation
08/07/2002CN1362145A Nano snake bile-fritillary-loquat medicine and its preparation
08/07/2002CN1362118A Nano liushen medicine and its preparation
08/07/2002CN1362115A Nano Guilin water melon medicine and its preparation
08/07/2002CN1362114A Nano Huodan medicine and its preparation
08/07/2002CN1362108A Nano rhinitis-treating drop medicine and its preparation
08/07/2002CN1362097A Nano Guilong Kechuanning medicine and its preparation
08/07/2002CN1362096A Nano phlegm-eliminating chlorite-schist medicine and its preparation
08/07/2002CN1362095A Nano bezoar-shake bile-fritillary medicine and its preparation
08/07/2002CN1362094A Nano reinforced loquet medicine and its preparation
08/07/2002CN1362092A Biantaoxian'an medicine for treating tonsillitis
08/07/2002CN1362091A Nano antiphlogistic bezoar medicine and its preparation
08/07/2002CN1362066A Nano Bingpeng medicine and its prepn
08/07/2002CN1088710C Water soluble repamycin esters
08/07/2002CN1088591C Medicine for curing and preventing upper respiratory infection and stopping-smoking, and its preparing method
08/07/2002CN1088589C Medicine composition for sthenia syndrome treatment of traditional Chinese medical science
08/07/2002CN1088581C Aerosol formulations of peptides and proteins
08/06/2002US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
08/06/2002US6429223 Modified forms of pharmacologically active agents and uses therefor
08/01/2002WO2002059308A2 Method of diagnosing and treating cartilage disorders
08/01/2002WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor
08/01/2002WO2002059295A1 Novel serine protease mp493
08/01/2002WO2002059286A2 Adenylate cyclases
08/01/2002WO2002059267A2 Constitutively desensitized g protein-coupled receptors
08/01/2002WO2002059126A1 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative
08/01/2002WO2002059114A1 Lfa-1 antagonist compounds
08/01/2002WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002WO2002059109A2 Naphthostyril derivatives and their use as inhibitors of cyclin- dependent kinases
08/01/2002WO2002059106A1 Isoindole-imide compounds, compositions, and uses thereof
08/01/2002WO2002059083A2 Novel compounds
08/01/2002WO2002058735A1 Method of preparing biological materials and preparation produced using same
08/01/2002WO2002058729A2 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies
08/01/2002WO2002058723A2 Chemokines as adjuvants of immune response
08/01/2002WO2002058713A1 Method for obtaining an isolated extract of the plant cyclamen europaeum l. and its use as a therapeutic agent
08/01/2002WO2002058705A2 Degradation-resistant glucocorticosteroid formulations
08/01/2002WO2002058702A1 Urotensin-ii receptor antagonists
08/01/2002WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
08/01/2002WO2002042278A3 Imidazole and benzimidazole caspase inhibitors and uses thereof
08/01/2002WO2002040461A3 Aminoalkoxybiphenyl carboxamides as histamine-3 receptor ligands and their therapeutic applications
08/01/2002WO2002036104A3 Inhalative solution formulation containing a tiotropium salt
08/01/2002WO2002032410A3 Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders
08/01/2002WO2002026733A3 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES
08/01/2002WO2002014319A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases
08/01/2002WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands
08/01/2002WO2002008285A3 Il-17 molecules and uses thereof
08/01/2002WO2002004509A3 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells
08/01/2002WO2002004497A3 Multiple antigenic peptides immunogenic against streptococcus pneumoniae
08/01/2002WO2001085148A3 Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride
08/01/2002WO2001083554A3 Anti-inflammatory compounds and uses thereof